Product image of Mycophenolatmofetil Accord (Mycophenolate Mofetil) supplied by GNH India

Mycophenolatmofetil Accord

Active Ingredient:
Mycophenolate Mofetil
Origin:
EU

Mycophenolatmofetil Accord (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycophenolatmofetil Accord, is an immunosuppressant (antimetabolite) presented as an oral tablet for oral use. It is used to prevent organ transplant rejection and to treat certain autoimmune kidney diseases.
GNH India supplies Mycophenolatmofetil Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mycophenolate Mofetil is employed in the management of immune‑mediated conditions where suppression of lymphocyte proliferation is required.
  • Kidney transplant: helps prevent acute and chronic rejection of the transplanted kidney.
  • Heart transplant: reduces the risk of graft rejection and improves graft survival.
  • Liver transplant: supports long‑term graft acceptance and lowers rejection episodes.
  • Lupus nephritis: diminishes renal inflammation and preserves kidney function in patients with systemic lupus erythematosus.

How It Works

  • Mycophenolate Mofetil is converted intracellularly to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase. This blocks de novo guanosine nucleotide synthesis, a pathway essential for proliferating T and B lymphocytes, thereby reducing their proliferation and dampening the immune response.

Side Effects

Adverse reactions may occur with Mycophenolate Mofetil therapy.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: frequent loose stools.
  • Abdominal pain: cramping or discomfort.
  • Vomiting: occasional episodes.
  • Headache: transient mild pain.
  • Tremor: fine shaking of hands.

Serious or Rare Side Effects

  • Opportunistic infections: increased susceptibility to viral, fungal, or bacterial infections.
  • Bone marrow suppression: leukopenia, anemia, or thrombocytopenia.
  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Malignancy: rare increased risk of certain cancers.
  • Severe allergic reactions: rash, angioedema, or anaphylaxis.
  • Progressive multifocal leukoencephalopathy (PML): rare but life‑threatening brain infection.

Precautions & Warnings

  • Patients receiving Mycophenolate Mofetil should be monitored closely for safety concerns.
  • Monitor blood counts: watch for leukopenia, anemia, or thrombocytopenia.
  • Assess renal function: adjust dose if creatinine clearance declines.
  • Check liver enzymes: detect early signs of hepatotoxicity.
  • Avoid live vaccines: risk of uncontrolled infection.
  • Use effective contraception: teratogenic potential is unknown.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Mycophenolate Mofetil can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Azathioprine: additive bone‑marrow suppression.
  • Live vaccines: heightened infection risk.
  • Cholestyramine or colestipol: reduces drug absorption.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may increase risk of hyperkalemia.
  • NSAIDs: can worsen renal impairment.
  • Antacids (aluminum or magnesium): may lower bioavailability.

Frequently Asked Questions

Mycophenolatmofetil Accord contains mycophenolate mofetil, an immunosuppressant used to prevent rejection after kidney, heart, or liver transplantation and to treat certain autoimmune kidney disorders such as lupus nephritis.

After oral administration, mycophenolate mofetil is converted to mycophenolic acid, which blocks inosine monophosphate dehydrogenase. This inhibition stops the synthesis of guanosine nucleotides needed for T‑ and B‑cell proliferation, thereby dampening the immune response.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s condition, weight, renal function, and other individual factors. Patients should follow the prescriber’s instructions exactly.

The safety of mycophenolate mofetil in pregnancy and lactation is not established. It is generally contraindicated in pregnant women because of potential teratogenic effects, and breastfeeding is not recommended unless the benefits outweigh the risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycophenolate mofetil offers a distinct mechanism by inhibiting guanosine synthesis, which differs from calcineurin inhibitors like tacrolimus that block T‑cell activation. It is often used in combination regimens to achieve synergistic immunosuppression while allowing lower doses of each agent.

Store the tablets at below 25 °C in a dry place. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

The medication is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The exact timing and frequency are prescribed by the treating physician.

Serious risks include opportunistic infections, bone‑marrow suppression leading to low blood counts, liver toxicity, and rare but severe conditions such as progressive multifocal leukoencephalopathy (PML) or life‑threatening allergic reactions.

Patients with known hypersensitivity to mycophenolate mofetil or any component of the formulation, those receiving live vaccines, and individuals with severe uncontrolled infections should avoid this medication. Clinicians must also assess renal and hepatic function before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolate Mofetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT